Pilaralisib

• Description:

  Pilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  541.02

• Molecular Formula:

  C25H25ClN6O4S

• Notes:

  Research use only, not for human use.

• Receptor:

  PI3Kα| PI3Kβ| PI3Kγ| PI3Kδ

• CAS Number:

  934526-89-3